SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-08-006313
Filing Date
2008-05-09
Accepted
2008-05-09 16:36:37
Documents
3
Period of Report
2008-07-02
Effectiveness Date
2008-05-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2185498zdef14a.htm DEF 14A 243499
2 G664867.JPG g664867.jpg GRAPHIC 2469
3 G869097.JPG g869097.jpg GRAPHIC 2990
  Complete submission text file 0001047469-08-006313.txt   252881
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15070 | Film No.: 08818925
SIC: 2834 Pharmaceutical Preparations